Tomasz Buczek, MPharm

Alfred Sokolowski Specialist Hospital in Walbrzych Oncology Support Centre for Clinical Trials; Department of Clinical Pharmacology, Wroclaw Medical University, Poland

Poster(s):

• 1406 - Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult Leukemia Group